RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, has elected Dr. Richard Bank and Dr. Stefan Loren to the Board of Directors.
